AGL 6.89 Decreased By ▼ -0.01 (-0.14%)
ANL 9.88 Increased By ▲ 0.11 (1.13%)
AVN 77.47 Increased By ▲ 0.65 (0.85%)
BOP 5.46 Decreased By ▼ -0.03 (-0.55%)
CNERGY 5.06 Increased By ▲ 0.01 (0.2%)
EFERT 79.49 Decreased By ▼ -0.34 (-0.43%)
EPCL 57.13 Decreased By ▼ -0.35 (-0.61%)
FCCL 15.38 Increased By ▲ 0.08 (0.52%)
FFL 6.65 Increased By ▲ 0.17 (2.62%)
FLYNG 7.47 Increased By ▲ 0.13 (1.77%)
GGGL 10.94 Increased By ▲ 0.19 (1.77%)
GGL 17.27 Increased By ▲ 0.33 (1.95%)
GTECH 8.50 Increased By ▲ 0.20 (2.41%)
HUMNL 6.55 Increased By ▲ 0.10 (1.55%)
KEL 3.06 Increased By ▲ 0.04 (1.32%)
LOTCHEM 29.47 Increased By ▲ 0.32 (1.1%)
MLCF 28.55 Increased By ▲ 0.25 (0.88%)
OGDC 77.00 Increased By ▲ 0.47 (0.61%)
PAEL 15.94 Increased By ▲ 0.07 (0.44%)
PIBTL 5.41 Decreased By ▼ -0.02 (-0.37%)
PRL 17.78 Increased By ▲ 0.09 (0.51%)
SILK 1.08 No Change ▼ 0.00 (0%)
TELE 10.89 Increased By ▲ 0.07 (0.65%)
TPL 8.67 Increased By ▲ 0.07 (0.81%)
TPLP 21.86 Increased By ▲ 0.67 (3.16%)
TREET 24.15 Increased By ▲ 0.35 (1.47%)
TRG 127.40 Decreased By ▼ -0.10 (-0.08%)
UNITY 23.19 Increased By ▲ 0.09 (0.39%)
WAVES 11.69 Increased By ▲ 0.06 (0.52%)
WTL 1.15 Increased By ▲ 0.01 (0.88%)
BR100 4,188 Increased By 14.5 (0.35%)
BR30 15,838 Increased By 31.7 (0.2%)
KSE100 41,719 Increased By 201 (0.48%)
KSE30 15,648 Increased By 86.1 (0.55%)
World

Chinese drugmakers agree to supply more than half a billion vaccines to COVAX

  • "The agreements, which come at a time when the Delta variant is posing a rising risk to health systems, will begin to make 110 million doses immediately available to participants of the COVAX Facility, with options for additional doses," GAVI said.
Published July 12, 2021
Follow us

GENEVA: The Global Alliance for Vaccines and Immunization (GAVI) said on Monday it had signed two advance purchase agreements with Chinese drugmakers Sinopharm and Sinovac to provide up to 550 million COVID-19 vaccines to the COVAX programme.

The new deals include up to 170 million doses of the Sinopharm shot and up to 380 million shots of the Sinovac vaccine, through to the middle of 2022, the statement said. Sinovac confirmed the agreement in a statement.

"The agreements, which come at a time when the Delta variant is posing a rising risk to health systems, will begin to make 110 million doses immediately available to participants of the COVAX Facility, with options for additional doses," GAVI said.

Vietnam receives 2 million COVID-19 vaccines to fight worst outbreak

GAVI, which runs the global vaccine sharing scheme COVAX with the World Health Organization (WHO) did not immediately provide details of which countries would receive the doses.

Deliveries can start quickly because both vaccines have already been granted emergency use listing by the WHO, GAVI Chief Executive Officer Seth Berkley said.

COVAX, which distributes vaccines to poorer countries, has struggled to meet its early commitments amid Indian export disruptions, forcing many countries to freeze their inoculation programmes in their early phases.

However, its latest supply forecast shows that the programme is on track to deliver more than 2 billion doses by early 2022. The vaccines by Sinovac and Sinopharm join nine other vaccines and vaccine candidates already in the programme including those by AstraZeneca and Moderna.

India expects 3-4 million Pfizer, Moderna vaccine doses through COVAX by August

Some countries including Thailand and Indonesia which used Sinovac as a first dose are switching to other shots for the second dose to increase protection against COVID-19.

GAVI did not immediately respond to a request for comment about whether it had concerns about the vaccine's efficacy.

The WHO said on June 1 when it approved Sinovac's shot that results showed it prevented symptomatic disease in 51% of those vaccinated and prevented severe COVID-19 and hospitalisation in 100% of the studied population.

The Sinopharm vaccine has an estimated efficacy of 79% for all age groups, the WHO said in early May when it approved the shot.

Comments

Comments are closed.